查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942759

2026年全球藥物釋放型球囊導管市場報告

Drug Eluting Balloons Catheters Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，藥物釋放型球囊導管市場發展迅速，預計將從2025年的16.5億美元成長到2026年的18.6億美元，複合年成長率達12.5%。過去幾年的成長可歸因於冠狀動脈疾病盛行率的上升、經皮冠狀動脈介入治療（PCI）的日益普及、球囊導管材料的技術進步、紫杉醇塗層器械的臨床應用以及介入性心臟病中心的擴張等因素。

預計未來幾年，藥物釋放型球囊導管市場將快速成長，到2030年市場規模將達到29.2億美元，複合年成長率（CAGR）為11.9%。預測期內的成長要素包括：對微創血管手術的需求不斷成長、基於Sirolimus的球囊導管應用日益廣泛、周邊血管疾病治療範圍不斷擴大、對下一代導管技術的投資不斷增加，以及對患者長期預後的日益關注。預測期內的主要趨勢包括：藥物塗層球囊技術的應用日益普及，其在冠狀動脈和周邊血管介入治療中的應用日益廣泛，無支架治療方法的偏好不斷增強，先進藥物塗層技術的推廣應用，以及對預防血管再阻塞再狹窄的日益重視。

預計未來幾年，周邊血管疾病和心血管疾病的日益普遍將推動藥物釋放型球囊導管市場的成長。心血管疾病（CVD）涵蓋多種影響心臟和循環系統的疾病，而周邊動脈疾病（PAD）則特別指動脈狹窄，主要導致四肢血流減少。藥物釋放型球囊導管用於治療冠狀動脈疾病（CAD），它由塗有抗增殖劑的半順應性血管成形術用氣球組成，這些抗增殖劑在與血管壁接觸時可防止血管再阻塞。例如，根據美國非營利組織美國心臟協會的數據，截至2024年1月，經年齡已調整的心血管疾病死亡率預計將上升至每10萬人233.3例，比2023年的每10萬人224.4例增加4.0%。因此，周邊血管疾病和心血管疾病盛行率的上升正在推動藥物釋放型球囊導管市場的擴張。

為了確保競爭優勢，藥物釋放型球囊導管市場的主要企業正致力於開發搭載先進技術的下一代產品。例如，2024年3月，總部位於美國的醫療設備和生技公司波士頓科學宣布，其AGENT藥物塗層球囊（DCB）已獲得美國食品藥物管理局（FDA）的核准。本產品是美國首個用於治療支架內血管再阻塞（ISR）的藥物塗層冠狀動脈球囊。支架內再狹窄是指支架植入後，斑塊或疤痕組織阻塞血管。 AGENT DCB塗覆紫杉醇，可將治療劑量的藥物輸送到血管壁，有效預防ISR復發，無需再次植入支架或接受放射治療。臨床試驗證實，該產品可使標靶部位心肌梗塞的風險降低49%，且不利事件發生率低。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球藥物釋放型球囊導管市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 藥物釋放型球囊技術的應用日益廣泛
    • 在冠狀動脈和周邊血管介入治療的應用日益增多
    • 擴大無支架治療方法方案
    • 拓展先進藥包衣技術
    • 人們越來越重視預防血管再阻塞。

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 門診手術中心
  • 導管檢查室
  • 心臟專科醫院
  • 血管治療中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球藥物釋放型球囊導管市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球藥物釋放型球囊導管市場規模、比較及成長率分析
  • 全球藥物釋放型球囊導管市場表現：規模與成長，2020-2025年
  • 全球藥物釋放型球囊導管市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 冠狀動脈疾病、周邊血管疾病、藥物釋放型球囊導管
  • 藥物
  • 紫杉醇、Sirolimus和其他藥物
  • 按原料
  • 尼龍、聚氨酯及其他原料
  • 最終用戶
  • 醫院/診所、門診手術中心、導管檢查室
  • 按類型細分：冠狀動脈疾病
  • 用於冠狀動脈的藥物釋放型球囊導管、用於冠狀動脈支架內血管再阻塞的藥物釋放型球囊導管、用於冠狀動脈小血管的藥物釋放型球囊導管
  • 按類型細分：周邊血管疾病
  • 藥物釋放型球囊導管、股膕動脈藥物釋放型球囊導管、膝下（BTK）藥物釋放型球囊導管
  • 按類型細分：藥物釋放型球囊導管
  • 藥物釋放型血管成形術球囊導管

第10章 區域與國家分析

  • 全球藥物釋放型球囊導管市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球藥物釋放型球囊導管市場：依國家、表現及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 藥物釋放型球囊導管市場：競爭格局及市場佔有率（2024年）
  • 藥物釋放型球囊導管市場：公司估值矩陣
  • 藥物釋放型球囊導管市場：公司概況
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • B Braun Melsungen Aktiengesellschaft
    • Terumo Corporation

第37章：其他領先和創新企業

  • Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年藥物釋放型球囊導管市場：提供新機會的國家
  • 2030年藥物釋放型球囊導管市場：充滿新機會的市場區隔
  • 2030年藥物釋放型球囊導管市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MDEBC01_G26Q1

A drug-eluting balloon catheter is a medical device utilized in the treatment of coronary artery disease through percutaneous coronary intervention (PCI). It is a semi-compliant angioplasty balloon that is coated with an anti-proliferative drug. During inflation, the drug is released into the vessel wall, aiming to prevent restenosis and reduce the risk of late thrombosis without the need for implanting a permanent foreign object.

The main types of drug-eluting balloon catheters include those designed for coronary artery disease and peripheral vascular disease. Coronary artery disease drug-eluting balloon catheters deliver antiproliferative drugs directly to the vessel wall using a lipophilic matrix, eliminating the need for a permanent structure such as a metal prosthesis or persistent polymer. Various drugs such as paclitaxel and sirolimus are used, and the catheters are made from raw materials such as nylon, polyurethane, and others. They find applications in hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.

Tariffs are influencing the drug eluting balloon catheters market by increasing costs of imported pharmaceutical coatings, catheter polymers, precision tubing, and manufacturing equipment used in coronary and peripheral devices. Hospitals and catheterization laboratories in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on device exports. These tariffs are increasing device pricing and procurement complexity. However, they are also encouraging localized catheter manufacturing, regional sourcing of raw materials, and investment in domestic production capabilities.

The drug eluting balloons catheters market research report is one of a series of new reports from The Business Research Company that provides drug eluting balloons catheters market statistics, including drug eluting balloons catheters industry global market size, regional shares, competitors with a drug eluting balloons catheters market share, detailed drug eluting balloons catheters market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting balloons catheters industry. This drug eluting balloons catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.65 billion in 2025 to $1.86 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing prevalence of coronary artery disease, growing adoption of percutaneous coronary interventions, advancements in balloon catheter materials, clinical acceptance of paclitaxel-coated devices, expansion of interventional cardiology centers.

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.92 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular therapies, rising adoption of sirolimus-based balloons, expansion of peripheral vascular disease treatments, growing investments in next-generation catheter technologies, increasing focus on long-term patient outcomes. Major trends in the forecast period include increasing adoption of drug-coated balloon technologies, rising use in coronary and peripheral interventions, growing preference for stent-free treatment options, expansion of advanced drug coating techniques, enhanced focus on restenosis prevention.

The increasing prevalence of peripheral and cardiovascular diseases is expected to drive the growth of the drug-eluting balloon catheter market in the coming years. Cardiovascular diseases (CVDs) encompass a range of conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically involves the narrowing of arteries that reduces blood flow, primarily to the arms or legs. Drug-eluting balloon catheters are used in the treatment of coronary artery disease (CAD) and consist of semi-compliant angioplasty balloons coated with anti-proliferative agents that, upon contact with the vessel wall, exert anti-restenotic effects. For example, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted cardiovascular disease mortality rate increased to 233.3 deaths per 100,000 in 2024, representing a 4.0% year-on-year rise from 224.4 deaths per 100,000 in 2023. Consequently, the growing prevalence of peripheral and cardiovascular diseases is contributing to the expansion of the drug-eluting balloon catheter market.

Key players in the drug-eluting balloon catheter market are intensifying their efforts to develop next-generation products with advanced technologies to secure a competitive advantage. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based biomedical and biotechnology engineering firm, announced it had received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB). This product is the first drug-coated coronary balloon available in the U.S. specifically designed for treating in-stent restenosis (ISR), a condition where plaque or scar tissue obstructs a previously stented vessel. The AGENT DCB features a paclitaxel coating that provides a therapeutic dose to the vessel wall, effectively reducing ISR recurrence without the need for additional stents or radiation. Clinical trials demonstrated a 49% reduction in the risk of heart attack at the target site, along with low rates of adverse events.

In June 2023, Translumina Therapeutics Company acquired Blue Medical Devices BV for an undisclosed amount. This strategic acquisition aimed to integrate Blue Medical's unique drug application technology into Translumina's product lines, expanding offerings in neurovascular and peripheral interventions and enhancing drug coating capabilities. Blue Medical Devices BV is a Netherlands-based medical device company specializing in producing drug-eluting balloon catheters.

Major companies operating in the drug eluting balloons catheters market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

North America was the largest region in the drug eluting balloons catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug eluting balloons catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug-eluting balloon catheter market consists of sales of everolimus and stellarex. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Eluting Balloons Catheters Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug eluting balloons catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug eluting balloons catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug eluting balloons catheters market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Coronary Artery Disease; Peripheral Vascular Disease; Drug-Eluting Balloon Catheters
  • 2) By Drug: Paclitaxel; Sirolimus; Other Drugs
  • 3) By Raw Material: Nylon; Polyurethane; Other Raw Materials
  • 4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Catheterization Laboratories
  • Subsegments:
  • 1) By Coronary Artery Disease: Coronary Drug-Eluting Balloon Catheters; Coronary In-Stent Restenosis Drug-Eluting Balloon Catheters; Coronary Small-Vessel Drug-Eluting Balloon Catheters
  • 2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters; Femoro-Popliteal Drug-Eluting Balloon Catheters; Below-the-Knee (BTK) Drug-Eluting Balloon Catheters
  • 3) By Drug-Eluting Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B Braun Melsungen Aktiengesellschaft; Terumo Corporation; Cook Medical LLC; Lepu Medical Technology Co. Ltd.; Meril Life Sciences Pvt. Ltd.; MicroPort Scientific Corporation; BIOTRONIK SE & Co. KG; Acotec Scientific Co. Ltd.; Cordis Corporation; Biosensors International Group Ltd.; Zylox-Tonbridge Medical Technology Co. Ltd.; Hexacath Limited; Zhejiang Barty Medical Technology Co. Ltd.; Cardionovum GmbH; Nano Therapeutics Pvt. Ltd.; Tokai Medical Products Inc.; Opto Circuits Limited; Acrostak (Schweiz) AG; Concept Medical Inc.; Aachen Resonance GmbH; AR Baltic Medical UAB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Drug Eluting Balloons Catheters Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Drug Eluting Balloons Catheters Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Drug Eluting Balloons Catheters Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Drug Eluting Balloons Catheters Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Drug-Coated Balloon Technologies
    • 4.2.2 Rising Use In Coronary And Peripheral Interventions
    • 4.2.3 Growing Preference For Stent-Free Treatment Options
    • 4.2.4 Expansion Of Advanced Drug Coating Techniques
    • 4.2.5 Enhanced Focus On Restenosis Prevention

5. Drug Eluting Balloons Catheters Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Catheterization Laboratories
  • 5.4 Cardiac Specialty Hospitals
  • 5.5 Vascular Treatment Centers

6. Drug Eluting Balloons Catheters Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Eluting Balloons Catheters Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Drug Eluting Balloons Catheters PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Drug Eluting Balloons Catheters Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Drug Eluting Balloons Catheters Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Drug Eluting Balloons Catheters Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Eluting Balloons Catheters Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Eluting Balloons Catheters Market Segmentation

  • 9.1. Global Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coronary Artery Disease, Peripheral Vascular Disease, Drug-Eluting Balloon Catheters
  • 9.2. Global Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Paclitaxel, Sirolimus, Other Drugs
  • 9.3. Global Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nylon, Polyurethane, Other Raw Materials
  • 9.4. Global Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories
  • 9.5. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Coronary Artery Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coronary Drug-Eluting Balloon Catheters, Coronary In-Stent Restenosis Drug-Eluting Balloon Catheters, Coronary Small-Vessel Drug-Eluting Balloon Catheters
  • 9.6. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Peripheral Vascular Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug-Eluting Balloon Catheters, Femoro-Popliteal Drug-Eluting Balloon Catheters, Below-the-Knee (BTK) Drug-Eluting Balloon Catheters
  • 9.7. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Drug-Eluting Balloon Catheters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug-Eluting Angioplasty Balloon Catheters

10. Drug Eluting Balloons Catheters Market Regional And Country Analysis

  • 10.1. Global Drug Eluting Balloons Catheters Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Drug Eluting Balloons Catheters Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Eluting Balloons Catheters Market

  • 11.1. Asia-Pacific Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Eluting Balloons Catheters Market

  • 12.1. China Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Eluting Balloons Catheters Market

  • 13.1. India Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Eluting Balloons Catheters Market

  • 14.1. Japan Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Eluting Balloons Catheters Market

  • 15.1. Australia Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Eluting Balloons Catheters Market

  • 16.1. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Eluting Balloons Catheters Market

  • 17.1. South Korea Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Eluting Balloons Catheters Market

  • 18.1. Taiwan Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Eluting Balloons Catheters Market

  • 19.1. South East Asia Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Eluting Balloons Catheters Market

  • 20.1. Western Europe Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Eluting Balloons Catheters Market

  • 21.1. UK Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Eluting Balloons Catheters Market

  • 22.1. Germany Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Eluting Balloons Catheters Market

  • 23.1. France Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Eluting Balloons Catheters Market

  • 24.1. Italy Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Eluting Balloons Catheters Market

  • 25.1. Spain Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Eluting Balloons Catheters Market

  • 26.1. Eastern Europe Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Eluting Balloons Catheters Market

  • 27.1. Russia Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Eluting Balloons Catheters Market

  • 28.1. North America Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Eluting Balloons Catheters Market

  • 29.1. USA Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Eluting Balloons Catheters Market

  • 30.1. Canada Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Eluting Balloons Catheters Market

  • 31.1. South America Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Eluting Balloons Catheters Market

  • 32.1. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Eluting Balloons Catheters Market

  • 33.1. Middle East Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Eluting Balloons Catheters Market

  • 34.1. Africa Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Eluting Balloons Catheters Market Regulatory and Investment Landscape

36. Drug Eluting Balloons Catheters Market Competitive Landscape And Company Profiles

  • 36.1. Drug Eluting Balloons Catheters Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Drug Eluting Balloons Catheters Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Drug Eluting Balloons Catheters Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. B Braun Melsungen Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Drug Eluting Balloons Catheters Market Other Major And Innovative Companies

  • Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited

38. Global Drug Eluting Balloons Catheters Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Eluting Balloons Catheters Market

40. Drug Eluting Balloons Catheters Market High Potential Countries, Segments and Strategies

  • 40.1 Drug Eluting Balloons Catheters Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Drug Eluting Balloons Catheters Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Drug Eluting Balloons Catheters Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer